TCL Archive ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer. March 24, 2006
TCL Archive New Year Sees Growing Attacks On Cancer Program; Critics Repeat Untrue Charges, OMB Continues January 3, 1975
TCL Archive Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate April 25, 2014